0001437749-23-008428.txt : 20230329
0001437749-23-008428.hdr.sgml : 20230329
20230329163110
ACCESSION NUMBER: 0001437749-23-008428
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230317
FILED AS OF DATE: 20230329
DATE AS OF CHANGE: 20230329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DONDERO JAMES D
CENTRAL INDEX KEY: 0001228922
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36066
FILM NUMBER: 23775641
MAIL ADDRESS:
STREET 1: 300 CRESCENT COURT
STREET 2: SUITE 700
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 PARK PLAZA
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 807-6600
MAIL ADDRESS:
STREET 1: 75 PARK PLAZA
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc
DATE OF NAME CHANGE: 20090130
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-03-17
0001178711
Paratek Pharmaceuticals, Inc.
PRTK
0001228922
DONDERO JAMES D
300 CRESCENT COURT, SUITE 700
DALLAS
TX
75201
1
0
Common Stock
2023-03-17
4
P
0
234863
1.50
A
2134663
I
See Footnote
Common Stock
2023-03-20
4
P
0
105137
1.40
A
2239770
I
See Footnote
Common Stock
2023-03-21
4
P
0
242500
1.74
A
1307617
I
See Footnote
Common Stock
2023-03-22
4
P
0
106000
1.77
A
2056000
I
See Footnote
Common Stock
2023-03-23
4
P
0
100000
1.73
A
2156000
I
See Footnote
Common Stock
50000
I
See Footnote
Common Stock
2889060
I
See Footnote
1,851,434 shares are held by Highland Global Allocation Fund, 64,770 shares are held by NexPoint Climate Tech Fund and 218,429 shares are held by NexPoint Event Driven Fund. These entities are managed by NexPoint Asset Management, L.P. ("NexPoint Asset Management"). Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of securities held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
1,950,000 shares are held by Highland Global Allocation Fund, 64,770 shares are held by NexPoint Climate Tech Fund and 225,000 shares are held by NexPoint Event Driven Fund. These entities are managed by NexPoint Asset Management. Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of securities held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.89, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of the shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
2,056,000 shares are held by Highland Global Allocation Fund, 64,770 shares are held by NexPoint Climate Tech Fund and 225,000 shares are held by NexPoint Event Driven Fund. These entities are managed by NexPoint Asset Management. Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of securities held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.71 to $1.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2,156,000 shares are held by Highland Global Allocation Fund, 64,770 shares are held by NexPoint Climate Tech Fund and 225,000 shares are held by NexPoint Event Driven Fund. These entities are managed by NexPoint Asset Management. Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of securities held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
50,000 shares are held by NexPoint Real Estate Opportunities Fund which is wholly owned by NexPoint Diversified Real Estate Trust Operating Partnership, L.P., which is wholly owned by NexPoint Diversified Real Estate Trust ("NXDT"). NXDT is advised indirectly by NexPoint Advisors, L.P. ("NP"). Mr. Dondero is the sole member of NP's general partner, and may be deemed to be an indirect beneficial owner of securities held by NP. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
2,889,060 shares are held by a trust of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.
/s/ James D. Dondero
2023-03-29